Literature DB >> 29856234

Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

Nathan C Bahr1,2,3, Ryan Halupnick1, Grace Linder1, Reuben Kiggundu2, Henry W Nabeta2, Darlisha A Williams1,2, Abdu K Musubire2, Bozena M Morawski1, Srinand Sreevatsan4, David B Meya1,2, Joshua Rhein1,2, David R Boulware1.   

Abstract

AIM: Tuberculosis meningitis (TBM) diagnosis is difficult, new biomarkers are needed. We evaluated the diagnostic utility of delta-like 1 protein (DLL1), vitamin D binding protein (VDBP) and fetuin.
METHODS: Biomarker concentrations were measured by ELISA in cryopreserved cerebrospinal fluid from 139 HIV-infected Ugandans with suspected meningitis. TBM was diagnosed by GeneXpert MTB/Rif or culture. Cohort diagnoses included TBM (n = 22), cryptococcal (n = 71), or aseptic meningitis (n = 16) and no meningitis (n = 30).
RESULTS: DLL1 (cut-off value 1150 pg/ml) provided 32% sensitivity and 98% specificity. Adding fetuin, cryptococcal antigen and IFN-γ resulted in sensitivities of 36, 63 and 76% with specificities of 98, 90 and 92%, respectively. VDBP (cut-off value 2.0 μg/ml) provided 81% sensitivity and 68% specificity while fetuin (cut-off value 2 μg/ml) provided a sensitivity of 86% and specificity of 68%.
CONCLUSION: CSF DLL1, VDBP and fetuin exhibited fair diagnostic performance for TBM diagnosis.

Entities:  

Keywords:  Mycobacterium tuberculosis; TB meningitis; biomarkers

Mesh:

Substances:

Year:  2018        PMID: 29856234      PMCID: PMC6161141          DOI: 10.2217/bmm-2017-0373

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  35 in total

1.  [Significance of soluble DLL1 in diagnosis of intracranial infectious diseases in children].

Authors:  Jin-Yi Li; Yan-Jie Jia; Yong-Lin Jia; Jing-Jing Lu; Li-Jun Jing; Tao Peng; Jing-Hong Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2011-03

2.  Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides.

Authors:  Ritu Bansal-Mutalik; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

3.  Molecular analysis of Mycobacterium tuberculosis causing multidrug-resistant tuberculosis meningitis.

Authors:  M Caws; G E Thwaites; P M Duy; D Q Tho; N T Ngoc Lan; D V Hoa; T T Hong Chau; M N Thu Huyen; P T Hoang Anh; N V V Chau; T N T Chinh; K Stepniewska; J Farrar
Journal:  Int J Tuberc Lung Dis       Date:  2007-02       Impact factor: 2.373

4.  Tuberculous meningitis in patients infected with the human immunodeficiency virus.

Authors:  J Berenguer; S Moreno; F Laguna; T Vicente; M Adrados; A Ortega; J González-LaHoz; E Bouza
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

Review 5.  Tuberculous meningitis in HIV-infected individuals.

Authors:  Christopher Vinnard; Rob Roy Macgregor
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

6.  Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone.

Authors:  Basem M Abdallah; Ming Ding; Charlotte H Jensen; Nicholas Ditzel; Allan Flyvbjerg; Thomas G Jensen; Frederik Dagnaes-Hansen; Jürg A Gasser; Moustapha Kassem
Journal:  Endocrinology       Date:  2007-04-19       Impact factor: 4.736

7.  Tuberculous meningitis: a uniform case definition for use in clinical research.

Authors:  Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais
Journal:  Lancet Infect Dis       Date:  2010-09-06       Impact factor: 25.071

8.  A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation.

Authors:  Wei Li; Shu Zhu; Jianhua Li; Yan Huang; Rongrong Zhou; Xuegong Fan; Huan Yang; Xing Gong; N Tony Eissa; Willi Jahnen-Dechent; Ping Wang; Kevin J Tracey; Andrew E Sama; Haichao Wang
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

9.  Biomarker discovery in subclinical mycobacterial infections of cattle.

Authors:  Meetu Seth; Elise A Lamont; Harish K Janagama; Andrea Widdel; Lucy Vulchanova; Judith R Stabel; W Ray Waters; Mitchell V Palmer; Srinand Sreevatsan
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

10.  Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.

Authors:  Nathan C Bahr; Edwin Nuwagira; Emily E Evans; Fiona V Cresswell; Philip V Bystrom; Adolf Byamukama; Sarah C Bridge; Ananta S Bangdiwala; David B Meya; Claudia M Denkinger; Conrad Muzoora; David R Boulware
Journal:  Lancet Infect Dis       Date:  2017-09-14       Impact factor: 25.071

View more
  8 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Methods for rapid diagnosis of meningitis etiology in adults.

Authors:  Victoria Poplin; David R Boulware; Nathan C Bahr
Journal:  Biomark Med       Date:  2020-04-09       Impact factor: 2.851

3.  Host-Derived Delta-Like Canonical Notch Ligand 1 as a Novel Diagnostic Biomarker for Bacterial Sepsis-Results From a Combinational Secondary Analysis.

Authors:  Dagmar Hildebrand; Sebastian O Decker; Christian Koch; Felix C F Schmitt; Sophie Ruhrmann; Emmanuel Schneck; Michael Sander; Markus Alexander Weigand; Thorsten Brenner; Klaus Heeg; Florian Uhle
Journal:  Front Cell Infect Microbiol       Date:  2019-07-23       Impact factor: 5.293

Review 4.  Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches.

Authors:  Charles M Manyelo; Regan S Solomons; Gerhard Walzl; Novel N Chegou
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

5.  Elevated Notch ligands in serum are associated with HIV/TB coinfection.

Authors:  Jennifer R Bermick; Pamela M Lincoln; Ronald M Allen; Steven L Kunkel; Matthew A Schaller
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-27

Review 6.  The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes.

Authors:  James A Seddon; Lillian Tugume; Regan Solomons; Kameshwar Prasad; Nathan C Bahr
Journal:  Wellcome Open Res       Date:  2019-11-05

7.  Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.

Authors:  Joseph Donovan; Fiona V Cresswell; Nguyen Thuy Thuong Thuong; David R Boulware; Guy E Thwaites; Nathan C Bahr
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

Review 8.  Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics.

Authors:  Fiona V Cresswell; Angharad G Davis; Kusum Sharma; Robindra Basu Roy; Ahmad Rizal Ganiem; Enock Kagimu; Regan Solomons; Robert J Wilkinson; Nathan C Bahr; Nguyen Thuy Thuong Thuong
Journal:  Wellcome Open Res       Date:  2021-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.